SSPN Knockout C2C12 Cell Line

The choice depends on whether you are studying SSPN's role in the dystrophin-glycoprotein complex (DGC) or modeling its emerging therapeutic potential in muscular dystrophy. The Knockout line is appropriate for asking whether SSPN is required for DGC stability, sarcolemmal integrity, or laminin binding in a muscle-relevant background. Overexpression is useful for testing SSPN's reported therapeutic effect in muscular dystrophy models — SSPN overexpression has been shown to compensate for dystrophin loss in mouse models. For muscle biology research, the EDITGENE SSPN Knockout in C2C12 is particularly relevant — C2C12 is the standard murine myoblast differentiation model, and SSPN expression increases during myogenic differentiation. Both KO and overexpression are valuable: KO reveals SSPN's contribution to DGC stability in differentiated myotubes, while overexpression tests its compensatory potential. Rescue with wild-type or domain-deletion SSPN dissects which protein regions mediate DGC stabilization.

Primary applications: • DGC stability assays: Western blot analysis of dystrophin-glycoprotein complex components (β-dystroglycan, sarcoglycans) in differentiated myotubes from knockout C2C12. • Myogenic differentiation: fusion index quantification and myotube morphology during differentiation, given SSPN's expression increases during myogenesis. • Laminin binding: integrin α7β1 and laminin-binding capacity assessment in the absence of SSPN. • Therapeutic potential studies: rescue with SSPN overexpression to test SSPN's reported ability to compensate for dystrophin loss in muscular dystrophy models. EDITGENE recommends this model for researchers investigating dystrophin-glycoprotein complex biology, muscular dystrophy mechanisms, and SSPN-based therapeutic strategies.

Yes. SSPN rescue experiments are particularly important given its therapeutic relevance for muscular dystrophy: • Construct design: use a codon-modified SSPN sequence with a small C-terminal cytoplasmic tag (FLAG, HA). SSPN is a tetraspanin-family membrane protein — N-terminal tags can interfere with membrane topology. • Differentiation-stage-specific rescue: SSPN expression normally increases during myogenic differentiation; rescue experiments should test both proliferating myoblast and differentiated myotube contexts. • Overexpression for therapeutic studies: SSPN overexpression has been shown to ameliorate dystrophin deficiency in mouse models — rescue at supraphysiological levels is informative for therapeutic mechanism studies. • Functional readout: rescue should restore DGC component levels (β-dystroglycan, sarcoglycans) and sarcolemmal stability during myotube formation. C2C12 transduces efficiently with lentivirus and standard expression vectors; the myogenic differentiation program is preserved through standard rescue protocols, enabling staged phenotypic analysis.